Healthcare services company Sotera Health (NASDAQ:) will be reporting results this Friday before market open. Here’s what to expect.

Sotera Health Company beat analysts’ revenue expectations by 3.1% last quarter, reporting revenues of $254.5 million, up 2.6% year on year. It was a strong quarter for the company, with a solid beat of analysts’ organic revenue estimates and a solid beat of analysts’ EPS estimates.

Is Sotera Health Company a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Sotera Health Company’s revenue to be flat year on year at $275.6 million, slowing from the 8.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.17 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Sotera Health Company has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Sotera Health Company’s peers in the research tools & consumables segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Mettler-Toledo delivered year-on-year revenue growth of 3.9%, beating analysts’ expectations by 2.9%, and Thermo Fisher reported revenues up 3%, topping estimates by 1.6%. Mettler-Toledo traded down 3% following the results while Thermo Fisher was up 11.3%.

Read our full analysis of Mettler-Toledo’s results here and Thermo Fisher’s results here.

Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the research tools & consumables stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.7% on average over the last month. Sotera Health Company is down 4.6% during the same time and is heading into earnings with an average analyst price target of $14.58 (compared to the current share price of $11.06).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft $(MSFT)$ to Alphabet $(GOOG)$, Coca-Cola $(KO)$ to Monster Beverage $(MNST)$ could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.